- Home
- BGLC vs DHAI Comparison
BGLC vs DHAI Comparison
Compare BGLC & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- DHAI
- Stock Information
- Founded
- BGLC 2017
- DHAI 2007
- Country
- BGLC Malaysia
- DHAI United States
- Employees
- BGLC N/A
- DHAI N/A
- Industry
- BGLC Medical Specialities
- DHAI
- Sector
- BGLC Health Care
- DHAI
- Exchange
- BGLC Nasdaq
- DHAI NYSE
- Market Cap
- BGLC 10.7M
- DHAI 11.6M
- IPO Year
- BGLC N/A
- DHAI N/A
- Fundamental
- Price
- BGLC $5.14
- DHAI $0.24
- Analyst Decision
- BGLC
- DHAI
- Analyst Count
- BGLC 0
- DHAI 0
- Target Price
- BGLC N/A
- DHAI N/A
- AVG Volume (30 Days)
- BGLC 3.1M
- DHAI 5.8M
- Earning Date
- BGLC 08-13-2025
- DHAI 08-18-2025
- Dividend Yield
- BGLC N/A
- DHAI N/A
- EPS Growth
- BGLC N/A
- DHAI N/A
- EPS
- BGLC N/A
- DHAI N/A
- Revenue
- BGLC $9,265,870.00
- DHAI $69,573,000.00
- Revenue This Year
- BGLC N/A
- DHAI N/A
- Revenue Next Year
- BGLC N/A
- DHAI N/A
- P/E Ratio
- BGLC N/A
- DHAI N/A
- Revenue Growth
- BGLC N/A
- DHAI 5.40
- 52 Week Low
- BGLC $2.01
- DHAI $0.12
- 52 Week High
- BGLC $15.60
- DHAI $3.34
- Technical
- Relative Strength Index (RSI)
- BGLC 55.54
- DHAI 49.09
- Support Level
- BGLC $3.57
- DHAI $0.23
- Resistance Level
- BGLC $7.05
- DHAI $0.25
- Average True Range (ATR)
- BGLC 1.44
- DHAI 0.02
- MACD
- BGLC -0.04
- DHAI -0.00
- Stochastic Oscillator
- BGLC 25.00
- DHAI 21.28
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
About DHAI DIH HOLDINGS US INC
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.